Figure 1
From: Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma
Analysis of the tissue-enriched genes in human cancers. (A) Schematic drawing describing the pipeline of the study. (B) Tissue and cancer categories included in the study and the corresponding sample size. Cancer types with <10 matching non-tumor samples were ruled out. As a result, 12 tissue types and 16 tumor types were selected, including 707 non-tumor samples and 7,091 tumor samples. Abbreviations: BLCA, bladder urothelial carcinoma. BRCA, breast invasive carcinoma. COAD, colon adenocarcinoma. ESCA, esophageal carcinoma. HNSC, head and neck squamous cell carcinoma. KICH, kidney chromophobe. KIRC, kidney renal clear cell carcinoma. KIRP, kidney renal papillary cell carcinoma. LIHC, liver hepatocellular carcinoma. LUAD, lung adenocarcinoma. LUSC, lung squamous cell carcinoma. PRAD, prostate adenocarcinoma. READ, rectum adenocarcinoma. STAD, stomach adenocarcinoma. THCA, thyroid carcinoma. UCEC, uterine corpus endometrial carcinoma.
